Selective Serotonin Reuptake Inhibitors
Selective serotonin re-uptake inhibitors or serotonin-specific reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders. A DrugBank category of 20 drugs. 14 of them are approved.
- ATC classification
- Part of
- Serotonin Modulators
- Also known as
- 5 HT Uptake Inhibitors · 5 Hydroxytryptamine Uptake Inhibitors · 5-HT Uptake Inhibitors · 5-Hydroxytryptamine Uptake Inhibitors · Antidepressants (Serotonin Reuptake Inhibitor/Antagonist)
What you can answer from here — as of September 25, 2018
Which targets do Selective Serotonin Reuptake Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account